Press releases
- Catalent, Inc. Reports Second Quarter Fiscal 2023 Results
- Catalent, Inc. Announces Second Quarter Fiscal Year 2023 Earnings Conference Webcast
- Catalent Appoints Ricardo Zayas as North American Biologics Operations Leader
- Sarepta and Catalent Expand Strategic Manufacturing Partnership With Commercial Supply Agreement for Duchenne Muscular Dystrophy Gene Therapy Candidate
- Catalent, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference
- Catalent Announces Changes to its Board of Directors
More ▼
Key statistics
Markit short selling activity
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 179.96m |
Free float | 179.31m |
P/E (TTM) | 31.68 |
Market cap | 12.88bn USD |
EPS (TTM) | 2.26 USD |
Data delayed at least 15 minutes.
More ▼